Targeting senescent cells in the retina with a BCL-xL inhibitor shows promise as a durable treatment for diabetic macular edema, potentially offering long-term visual function improvements.
Out-of-Pocket Insulin Caps Boost Savings — But Not Insulin Use
While out-of-pocket caps on insulin indeed cut down on costs for commercially insured patients in the U.S., the policies didn’t do much to increase insulin